Criteria of prescription of antibiotics and systemic corticosteroids among pulmonologists and general practictioners during asthma and COPD exacerbations: a southern Italian survey

Silvano Dragonieri; Pierluigi Carratu; Teresa Ranieri; Giovanna Elisiana Carpagnano; Onofrio Resta

doi:10.23750/abm.v92i3.9909

Criteria of prescription of antibiotics and systemic corticosteroids among pulmonologists and general practictioners during asthma and COPD exacerbations: a southern Italian survey

Authors

Silvano Dragonieri a:1:{s:5:"en_US";s:40:"Respiratory Diseases, University of Bari";}
Pierluigi Carratu
Teresa Ranieri
Giovanna Elisiana Carpagnano
Onofrio Resta

DOI: https://doi.org/10.23750/abm.v92i3.9909

Keywords:

asthma, COPD, exacerbation, corticosteroids, antibiotics, prescribing criteria

Abstract

To date, there is still a lack of unanimity regarding the definition of exacerbation of asthma and COPD and about objective measurements in the currently used criteria. The aim of our study was to conduct a survey among general practitioners (GPs) and pulmonologists regarding the clinical criteria arbitrarily considered as important to start a course of systemic corticoids and/or antibiotics in asthma and COPD.

We conducted a survey enrolling 50 general practitioners (GPs) and 50 pulmonologists, that evaluated the clinical criteria arbitrated as essential to start a course of systemic corticosteroids or antibiotics during asthma and/or COPD exacerbations. Our results demonstrated incongruities between GPs and pulmonologist and within the same professional category concerning systemic corticosteroids. Conversely, we showed higher consensus between and within the groups about criteria to prescribe antibiotics.

References

Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-178.

Neumeier A, Keith R. Clinical Guideline Highlights for the Hospitalist: The GOLD and NICE Guidelines for the Management of COPD. J Hosp Med 2020;11:e1-e2.

Montes de Oca M, Laucho-Contreras ME. Is It Time to Change the Definition of Acute Exacerbation of Chronic Obstructive Pulmornary Disease? What Do We Need to Add? Med Sci 2018;14:6(2).

Louis R, Ziant S, Duchesnes C, et al. Exacerbations in asthma and chronic obstructive pulmonary disease (COPD) Survey on the criteria of prescription of systemic corticoids and antibiotics by general practicioners and chest physicians. Rev Med Liege 2018;73:570-574.

Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999; 160:594-599.

Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364-369.

Demarche SF, Schleich FN, Paulus VA, et al. Is it possible to claim or refute sputum eosinophils >/= 3% in asthmatics with sufficient accuracy using bio- markers? Respir Res 2017;18:133.

Meijer RJ, Postma DS, Kauffman HF, et al. Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin Exp Allergy 2002;32: 1096-1103.